注册并分享邀请链接,可获得视频播放与邀请奖励。

Wall St Engine
@wallstengine
Fast, accurate, consistent stock market news, earnings highlights & more. By Brillinsight. Not financial advice.
加入 March 2022
999 正在关注    224.3K 粉丝
ZIMMER BIOMET $ZBH Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $2.06B (Est. $2.04B) 🟢; +3.1% YoY 🔹 Adj. EPS: $1.90 (Est. $1.88) 🟢 🔹 Adj. Operating Profit: $518.8M (Est. $510M) 🟢 Raises FY26 Guide: 🔹 Adj. EPS: $8.50-$8.60 (Est. $8.54) 🟡 🔹 Reported Revenue Growth: 4.4%-4.9% (Est. +4.4%) 🟡 🔹 Constant Currency Revenue Growth: 4.1%-4.6% 🔹 Organic cc Revenue Growth: 3.0%-3.5% Other Q3 Metrics: 🔹 Operating Cash Flow: $560.0M 🔹 Free Cash Flow: $372.4M 🔹 Reported Net Sales Growth: +3.1% 🔹 Constant Currency Growth: +3.7% Segment Net Revenue: 🔹 Knees: $767.5M; -3.1% YoY (Est. $791.6M) 🔴 🔹 Hips: $536.5M; +6.0% YoY (Est. $514.8M) 🟢 🔹 S.E.T.: $578.3M; +6.8% YoY 🔹 Technology & Data, Bone Cement and Surgical: $180.6M; +11.9% YoY Comments: 🔸 “This broad-based performance gives us confidence to raise our full-year organic constant-currency sales growth and adjusted EPS guidance.”
显示更多